Alfa Laval Corporate AB

Alfa Laval Corporate AB

ALFVF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$22.5B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Alfa Laval Corporate ABAlfa Laval Corporate AB27.81.64%16%0.30.7

Earnings Call Q3 2026

October 27, 2026 - AI Summary

Record orders + strong, broad demand tailwinds (but Q4 deceleration expected) - Q3 order intake: SEK 23.2bn (new record; notable given seasonally softer Q3). - Order book: new record just below SEK 60bn; Energy/Food & Pharma/Ocean all within target profitability ranges. - Sales & profit growth were “normalized”: Sales +8%, profit +6% YoY (vs. orders much stronger than sales). - Divisional themes: - Energy: strong; data centers + HVAC/heat pumps + power/fuel. - Food & Pharma: solid; transactional business at record; biofuels projects notable. - Ocean (Marine): ship contracting exceptional; cargo pumping converting to orders. - Outlook/Q4 expectation: after two record quarters, management expects somewhat lower demand in Q4 than Q3 (Energy ~same; Food & Pharma ~lower; Ocean lower).
CapEx increased—investment cycle likely peaks in 2028 (key investor watch item) - CapEx guidance raised (accelerated growth): from SEK 3bn to SEK 4bn per year. - Planned peaks next: guided 2026 CapEx increased; Q4 2026 ≈ SEK 1bn, 2027 ≈ SEK 4bn (and amortization step-ups guided too). - Why increase: ramping capacity for data centers (Energy) and other growth needs; also manufacturing footprint optimization and service/systems capacity. - “Peak cycle” narrative: management believes CapEx peak around 2027–2028, then returns to lower run-rate after completion; no new major capacity decisions expected to materially impact 2030.
Profitability steady at targets; margins affected by mix (especially in Ocean service/pumping dynamics) - Group profitability: Adjusted EBITA margin ~18.1% in Q3 (all 3 divisions at target ranges). - Divisional EBITA margins (Q3): Energy 18.1%, Food & Pharma 15.5%, Ocean 21.3%. - Cost/R&D: sales & admin +10% (inflation, acquisitions, added resources); R&D +7%. - Ocean headwinds/negative surprise: Service declined in Ocean (sanctions—~4,000 ships out of scope from ~60,000 merchant fleet), plus intense fleet utilization delaying service intervals; mix also swung toward less pumping/service in Q3.

Exclusive for Stockcircle Pro members

Sign upSign Up
$31.77

Current Fair Value

45% downside

Overvalued by 45% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$22.50 Billion
Enterprise Value$48.60 Billion
Annual dividend$0.98
Dividend yield1.64%
Earnings per Share$19.96
Beta0.79
Outstanding Shares413,326,315

Return

Return on Equity16.16%ROE
Return on Assets7.19%
Return on Invested Capital16.68%

Valuation & Multiples

P/E Ratio27.83P/E Ratio
PEG-2987.24PEG
Price to Sales0.34Price to Sales
Price to Book Ratio0.47Price to Book Ratio
Enterprise Value to Revenue0.68
Enterprise Value to EBIT4.17
Enterprise Value to Net Income5
Total Debt to Enterprise0.68
Debt to Equity0.66Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
October 27, 2026
EPS
$0.54
Est. $0.57
Revenue
$1.85 B
Est. $1.86 B

Next Earnings Call

Expected Date
February 3, 2027
EPS Estimate
$0.63
Consensus analyst estimate
Revenue Estimate
$2.07 B
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Alfa Laval Corporate AB

24,832 employees
CEO: Tom Erixon

Alfa Laval Corporate AB stands as a prominent global provider of advanced industrial solutions, specializing in heat transfer, separation, and fluid management technologies. The company strategically operates through three core divisions...

Questions & Answers